PHS
PFM Health Sciences’s Cytokinetics CYTK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,757,192
| Closed | -$92.8M | – | 81 |
|
|
2024
Q3 | $92.8M | Hold |
1,757,192
| – | – | 5.26% | 3 |
|
|
2024
Q2 | $95.2M | Hold |
1,757,192
| – | – | 4.71% | 2 |
|
|
2024
Q1 | $123M | Hold |
1,757,192
| – | – | 5.79% | 2 |
|
|
2023
Q4 | $147M | Sell |
1,757,192
-642,353
| -27% | -$53.6M | 8.8% | 2 |
|
|
2023
Q3 | $70.7M | Hold |
2,399,545
| – | – | 3.33% | 4 |
|
|
2023
Q2 | $78.3M | Hold |
2,399,545
| – | – | 3.04% | 4 |
|
|
2023
Q1 | $84.4M | Hold |
2,399,545
| – | – | 3.73% | 4 |
|
|
2022
Q4 | $110M | Sell |
2,399,545
-65,471
| -3% | -$3M | 3.94% | 2 |
|
|
2022
Q3 | $119M | Hold |
2,465,016
| – | – | 4.32% | 1 |
|
|
2022
Q2 | $96.9M | Hold |
2,465,016
| – | – | 3.69% | 2 |
|
|
2022
Q1 | $90.7M | Hold |
2,465,016
| – | – | 3.39% | 6 |
|
|
2021
Q4 | $112M | Sell |
2,465,016
-694,685
| -22% | -$31.7M | 3.83% | 5 |
|
|
2021
Q3 | $113M | Buy |
3,159,701
+1,472,689
| +87% | +$52.6M | 3.32% | 5 |
|
|
2021
Q2 | $33.4M | Buy |
1,687,012
+150,639
| +10% | +$2.98M | 1.05% | 37 |
|
|
2021
Q1 | $35.7M | Buy |
1,536,373
+565,222
| +58% | +$13.1M | 1.09% | 30 |
|
|
2020
Q4 | $20.2M | Buy |
+971,151
| New | +$20.2M | 0.71% | 47 |
|